HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 471.01 thousand shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2019-09-30 was 241.12K shares, a 17.18% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2019-06-30 was 134.37K shares, a 251.43% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2019-03-31 was 95.51K shares, a 459.25% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-12-31 was 10.50K shares, a 30.17% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2018 was 356.96K shares, a 317.37% increase from fiscal 2017.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2017 was 85.53K shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2016 was -34.58K shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2015 was -10.34K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | 241.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 375.50K shares derived: sum of 2 quarters · filed 2019-11-08 | 471.01K shares 10-Q · filed 2019-11-08 | 481.51K shares derived: sum of 4 quarters · filed 2019-11-08 | |
| 2019-06-30 | 134.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 229.88K shares 10-Q · filed 2019-08-08 | 240.39K shares derived: sum of 3 quarters · filed 2019-08-08 | 531.53K shares derived: sum of 4 quarters · filed 2019-08-08 | |
| 2019-03-31 | 95.51K shares 10-Q · filed 2019-05-08 | 106.01K shares derived: sum of 2 quarters · filed 2019-05-08 | 397.16K shares derived: sum of 3 quarters · filed 2019-05-08 | 435.40K shares derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-12-31 | 10.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 301.65K shares derived: sum of 2 quarters · filed 2019-03-18 | 339.89K shares derived: sum of 3 quarters · filed 2019-03-18 | 356.96K shares 10-K · filed 2019-03-18 | |
| 2018-09-30 | 291.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 329.38K shares derived: sum of 2 quarters · filed 2018-11-01 | 346.46K shares 10-Q · filed 2018-11-01 | 361.50K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-06-30 | 38.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 55.31K shares 10-Q · filed 2018-08-02 | 70.36K shares derived: sum of 3 quarters · filed 2019-03-18 | 80.48K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-03-31 | 17.08K shares 10-Q · filed 2018-05-10 | 32.12K shares derived: sum of 2 quarters · filed 2019-03-18 | 42.24K shares derived: sum of 3 quarters · filed 2019-03-18 | 98.42K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-12-31 | 15.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 25.16K shares derived: sum of 2 quarters · filed 2019-03-18 | 81.34K shares derived: sum of 3 quarters · filed 2019-03-18 | 85.53K shares 10-K · filed 2019-03-18 | -85.53K shares 10-K · filed 2018-03-16 |
| 2017-09-30 | 10.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 66.30K shares derived: sum of 2 quarters · filed 2017-11-02 | 70.49K shares 10-Q · filed 2017-11-02 | 4.13K shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2017-06-30 | 56.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 60.37K shares 10-Q · filed 2017-08-03 | -5.99K shares derived: sum of 3 quarters · filed 2018-03-16 | 153.00 shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2017-03-31 | 4.19K shares 10-Q · filed 2017-05-08 | -62.17K shares derived: sum of 2 quarters · filed 2018-03-16 | -56.02K shares derived: sum of 3 quarters · filed 2018-03-16 | -30.39K shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-12-31 | -66.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -60.21K shares derived: sum of 2 quarters · filed 2018-03-16 | -34.58K shares derived: sum of 3 quarters · filed 2018-03-16 | -34.58K shares 10-K · filed 2018-03-16 | |
| 2016-09-30 | 6.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 31.78K shares derived: sum of 2 quarters · filed 2016-11-03 | 31.78K shares 10-Q · filed 2016-11-03 | 21.45K shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | 25.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 25.64K shares 10-Q · filed 2016-08-04 | 15.30K shares derived: sum of 3 quarters · filed 2018-03-16 | 15.30K shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-16 | -10.34K shares derived: sum of 2 quarters · filed 2018-03-16 | -10.34K shares derived: sum of 3 quarters · filed 2018-03-16 | -10.34K shares derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | -10.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -10.34K shares derived: sum of 2 quarters · filed 2018-03-16 | -10.34K shares derived: sum of 3 quarters · filed 2018-03-16 | -10.34K shares 10-K · filed 2018-03-16 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2015-11-05 | 0.00 shares 10-Q · filed 2015-11-05 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 0.00 shares 10-Q · filed 2015-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-17 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-17 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-17 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-17 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-17 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-17 | -40.88K shares 10-K · filed 2017-03-17 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-06 | -40.88K shares 10-Q · filed 2014-11-06 | -93.32K shares derived: sum of 4 quarters · filed 2016-04-29 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -40.88K shares 10-Q · filed 2014-08-07 | -93.32K shares derived: sum of 3 quarters · filed 2016-04-29 | -93.32K shares derived: sum of 4 quarters · filed 2016-04-29 | |
| 2014-03-31 | -40.88K shares 10-Q · filed 2014-05-08 | -93.32K shares derived: sum of 2 quarters · filed 2016-04-29 | -93.32K shares derived: sum of 3 quarters · filed 2016-04-29 | ||
| 2013-12-31 | -52.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -52.45K shares derived: sum of 2 quarters · filed 2016-04-29 | -191.50K shares 10-K · filed 2016-04-29 | ||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -139.06K shares 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | -139.06K shares 10-Q · filed 2013-08-09 | ||||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-12 | -47.46K shares 10-K · filed 2015-03-12 | ||
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -47.46K shares 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | -47.46K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |